Intentional and non-intentional non-adherence to medication amongst breast cancer patients

Atkins, Louise, Fallowfield, Lesley·2006·European Journal of Cancer

Cited by (300)

Items 101–200 of 300

  1. Adherence to Intravenous Chemotherapy in African American and White Women With Early-Stage Breast Cancer
    Jessica Wells, Ora Lea Strickland, Jo Ann Dalton, Sarah Freeman · 2014 · Cancer Nursing
  2. Patients’ self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis
    Kazuyoshi Kawakami, Takashi Yokokawa, Eri Nakamoto, Kazuo Sugita, Akane Hagino, Mitsukuni Suenaga, Nobuyuki Mizunuma, Sayaka Oniyama, Yoshiaki Machida, Toshiharu Yamaguchi et al. · 2015 · Patient Preference and Adherence
  3. Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions
    Vicente Francisco Gil-Guillén, Alejandro Balsa, Beatriz Bernárdez, Carmen Valdés y Llorca, Emilio Márquez Contreras, Juan de la Haba-Rodríguez, Jose Maria Castellano, Jesús Carlos Gómez Martínez · 2022 · International Journal of Environmental Research and Public Health
  4. Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy
    Sophie M C Green, David French, Christopher D. Graham, Louise Hall, Nikki S. Rousseau, Robbie Foy, Jane Clark, Catherine Parbutt, Erin Raine, Benjamin Gardner et al. · 2022 · BMC Health Services Research
  5. The impact of a supplementary medication review and counselling service within the oncology outpatient setting
    H Read, S Ladds, B Rhodes, D Brown, Jane Caroline Portlock · 2007 · British Journal of Cancer
  6. Health Literacy and Medication Adherence in Underserved African-American Breast Cancer Survivors: A Qualitative Study
    Connie F. Rust, Cindy Davis · 2011 · Social Work in Health Care
  7. Patient Adherence to Aromatase Inhibitor Treatment in the Adjuvant Setting
    Sunil Verma, Yolanda Madarnas, Sandeep R. Sehdev, Ginette Martin, Jana Bajcar · 2011 · Current Oncology
  8. Intelligence and persisting with medication for two years: Analysis in a randomised controlled trial
    Ian J. Deary, Catharine R. Galé, Marlene C. W. Stewart, F.G.R. Fowkes, Gordon D. Murray, George David Batty, Jacqueline F. Price · 2009 · Intelligence
  9. Disentangling breast cancer patients' perceptions and experiences with regard to endocrine therapy: Nature and relevance for non-adherence
    Hans Wouters, Erica C.G. van Geffen, Monique C.M. Baas-Thijssen, Elly MM Krol-Warmerdam, Anne Margarethe Stiggelbout, Svetlana V. Belitser, Marcel L. Bouvy, Liset van Dijk · 2013 · The Breast
  10. The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis
    Christopher Jackson, Leila Finikarides, Alexandra L. J. Freeman · 2022 · PLoS ONE
  11. Evaluation of patients\' adherence to chemotherapy for breast cancer
    Adewale Adisa, OO Lawal, A. R. K. Adesunkanmi · 2008 · African Journal of Health Sciences
  12. A qualitative study exploring the lived experience of medication use in different disease states: Linking experiences of disease symptoms to medication adherence
    Adam Pattison Rathbone, Kimberly Jamie, Adam Todd, Andy Husband · 2020 · Journal of Clinical Pharmacy and Therapeutics
  13. Impacts of a navigation program based on health information technology for patients receiving oral anticancer therapy: the CAPRI randomized controlled trial
    Chloé Gervès‐Pinquié, Fatima Yatim, Benoît Lalloué, Anne Girault, Marie Ferrua, A. Fourcade, François Lemare, Mario DiPalma, Étienne Minvielle · 2017 · BMC Health Services Research
  14. Strategies to Improve Medication Adherence Reported by Diabetes Patients and Caregivers: Results of a Taking Control of Your Diabetes Survey
    Candis M. Morello, Megan E. Chynoweth, Hoim Kim, Renu F Singh, Jan D. Hirsch · 2011 · Annals of Pharmacotherapy
  15. Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study
    Heidi D. Klepin, Ann M. Geiger, Hanna Bandos, Joseph P. Costantino, Stephen R. Rapp, Kaycee M. Sink, Julia A. Lawrence, Hal H. Atkinson, Mark Andrew Espeland · 2013 · Cancer Prevention Research
  16. Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer
    Arden L. Corter, Reuben James Broom, David J.T. Porter, Vernon J. Harvey, Michael P. N. Findlay · 2018 · Psycho-Oncology
  17. Comparison of individual perceptions of medication costs and benefits between intentional and unintentional medication non-adherence among Japanese patients
    Naomi Iihara, Yuji Kurosaki, Chika Miyoshi, Kiyo Takabatake, SHUSHI MORITA, Keizo Hori · 2008 · Patient Education and Counseling
  18. Adherence to Capecitabine Treatment and Contributing Factors among Cancer Patients in Malaysia
    Abdul Kadir Zahrina, Bachok Norsa’adah, Norul Badriah Hassan, Yaacob Norazwany, Md Isa Norhayati, Mohd Roslan Haron, Wan Rusik Wan Nazuha · 2014 · Asian Pacific Journal of Cancer Prevention
  19. Antiangiogenic strategies in breast cancer management
    Monica Giovannini, D. Aldrighetti, Patrizia Zucchinelli, Carmen Belli, Eugenio Villa · 2010 · Critical Reviews in Oncology/Hematology
  20. Patient-reported outcomes of the relative severity of side effects from cancer radiotherapy
    Patrick A. Williams, Shu Cao, Dongyun Yang, Richard L. S. Jennelle · 2019 · Supportive Care in Cancer
  21. Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93
    Olivia Pagani, Shari I. Gelber, Marco Angelo Colleoni, Karen N. Price, Edda Simoncini · 2013 · Breast Cancer Research and Treatment
  22. Systematic review of the health and societal effects of medication organisation devices
    Steven James Watson, Clare F Aldus, Christine M Bond, Debi Bhattacharya · 2016 · BMC Health Services Research
  23. Experiences and desired nursing assistance of women on out‐patient breast cancer chemotherapy in Southeastern Nigeria
    Agnes Nonyem Anarado, Emmanuel Ezeome, O. B. Ofi, Ada Carol Nwaneri, Yolanda Ogbolu · 2015 · Psycho-Oncology
  24. Factors Associated with Non-Adherence to HBV Antiviral Therapy
    Suzanne Sheppard‐Law, Iryna Zablotska, Melissa Kermeen, Susan Holdaway, Alice M. Lee, Jacob George, Amany Zekry, Lisa Maher · 2017 · Antiviral Therapy
  25. Adherence to Adjuvant Endocrine Therapy for Breast Cancer: Importance in Women with Low Income
    Carling Jade Ursem, Hayden Barry Bosworth, Rebecca A. Shelby, Wenke Hwang, Roger T. Anderson, Gretchen Genevieve Kimmick · 2015 · Journal of Women s Health
  26. Improving patient outcomes in psoriasis: strategies to ensure treatment adherence
    L. Puig, Oriol Yélamos, Sandra Ros · 2015 · Psoriasis Targets and Therapy
  27. Treatment interruption and discontinuation of hormonal therapy in hormone receptor-positive breast cancer patients
    Daqin Mao, Hilal Hachem, Hong Chang, Danai Dima, Joshua Dower, Michael Wismer, John Kalil Erban, Karen M. Freund, Susan Kenyon Parsons · 2020 · Breast Cancer Research and Treatment
  28. Fulvestrant: Expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer
    Stephen Chia, William John Gradishar · 2008 · The Breast
  29. Improving medication adherence: a framework for community pharmacy-based interventions
    Janice L. Pringle, Kim C. Coley · 2015 · Integrated Pharmacy Research and Practice
  30. Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: Protocol for a pilot fractional factorial trial
    Smith, Samuel G, Green, Sophie M C, Ellison, Rachel, Foy, Robbie, Graham, Christopher D, Mason, Ellen, French, David P, Hall, Louise H, Wilkes, Hollie, McNaught, Emma et al. · 2023 · BMJ Open
  31. Providers of follow-up care in a population-based sample of breast cancer survivors
    Christopher Ryan Friese, Kathryn Anne Martinez, Paul H. Abrahamse, Ann S. Hamilton, John J. Graff, Reshma Jagsi, Jennifer J. Griggs, Sarah T. Hawley, Steven Jay Katz · 2014 · Breast Cancer Research and Treatment
  32. Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study
    Aliana Guerrieri‐Gonzaga, Matteo Lazzeroni, Edoardo Botteri, Davide Serrano, Nicole Rotmensz, M C Varricchio, Marina Elena Cazzaniga, Giorgia Bollani, Serena Mora, Chiara Montefrancesco et al. · 2013 · Annals of Oncology
  33. Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data
    Vanessa B. Sheppard, Jun He, Arnethea L. Sutton, Lee Cromwell, Georges Adunlin, Teresa M. Salgado, Dennis Tolsma, Martha Trout, Brandi E. Robinson, Megan C. Edmonds et al. · 2019 · Journal of Managed Care & Specialty Pharmacy
  34. Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)
    Shelby, Rebecca A., Dorfman, Caroline S., Bosworth, Hayden B., Keefe, Francis, Sutton, Linda, Owen, Lynda, Corsino, Leonor, Erkanli, Alaattin, Reed, Shelby D., Arthur, Sarah S. et al. · 2019 · Contemporary Clinical Trials
  35. La chimiothérapie par voie orale: représentations et pratiques des oncologues et des patients
    Véronique Régnier Denois, J. Poirson, Fanny Soum-Pouyalet, Franck Chauvin · 2009 · Psycho-Oncologie
  36. Comparing patient dissatisfaction and rational judgment in intentional medication non-adherence versus unintentional non-adherence
    Naomi Iihara, Takayuki Nishio, M. Okura, Hideaki Anzai, Masatoshi Kagawa, Hitoshi Houchi, Yutaka Kirino · 2013 · Journal of Clinical Pharmacy and Therapeutics
  37. Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer
    Kazuyoshi Kawakami, Takashi Yokokawa, Kazuo Kobayashi, Takahito Sugisaki, Kenichi Suzuki, Mitsukuni Suenaga, Kensei Yamaguchi, Ayaka Inoue, Yoshiaki Machida, Toshiharu Yamaguchi et al. · 2017 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  38. Smartphone Applications for Educating and Helping Non-motivating Patients Adhere to Medication That Treats Mental Health Conditions: Aims and Functioning
    Angelos P. Kassianos, Giοrgos Georgiou, Electra P. Papaconstantinou, Angeliki Detzortzi, Robert Horne · 2017 · Frontiers in Psychology
  39. Adherence to Adjuvant Aromatase Inhibitor Therapy Among Postmenopausal Hispanic/Latino Women With Breast Cancer
    Alexander V. Philipovskiy, Aleli Campbell, Rosalinda Heydarian, Brenda Sofia Castillo, Alok Kumar Dwivedi, Richard W. McCallum, Renato J. Aguilera, Sumit Gaur, Zeina A. Nahleh · 2020 · Anticancer Research
  40. Association Between the Health Locus of Control and Medication Adherence: An Observational, Cross-Sectional Study in Primary Care
    H. Gerland, T. Prell · 2021 · Frontiers in Medicine
  41. Quality of life issues in relation to the aromatase inhibitor
    Lesley J. Fallowfield · 2007 · The Journal of Steroid Biochemistry and Molecular Biology
  42. Acceptance and Commitment Therapy to support medication decision-making and quality of life in women with breast cancer: protocol for a pilot randomised controlled trial
    Smith, Samuel G., Ellison, Rachel, Hall, Louise, Clark, Jane, Hartley, Suzanne, Mason, Ellen, Metherell, Jamie, Olivier, Catherine, Napp, Vicky, Naik, Jay et al. · 2022 · Pilot and Feasibility Studies
  43. Risks of nonadherence to hormone therapy in Asian women with breast cancer
    Kun‐Pin Hsieh, Li‐Chia Chen, Kwok‐Leung Cheung, Yi‐Hsin Yang · 2015 · The Kaohsiung Journal of Medical Sciences
  44. Predictors of non-adherence to systemic oral therapy for advanced hepatocellular carcinoma
    Rajiv Mallick, Jennifer X. Cai, Jenifer Wogen · 2013 · Current Medical Research and Opinion
  45. An evaluation of hepatitis C knowledge and correlations with health belief model constructs among African American “baby boomers”
    Mohamed Rashrash, Mary K. Maneno, Anthony K. Wutoh, Earl B. Ettienne, Monika N. Daftary · 2015 · Journal of Infection and Public Health
  46. Antidepressants in primary care: patients’ experiences, perceptions, self-efficacy beliefs, and nonadherence
    Hans Wouters, Marcel L. Bouvy, Katja Van Geffen, Helga Gardarsdóttir, Anne Margarethe Stiggelbout, Liset van Dijk · 2014 · Patient Preference and Adherence
  47. Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Through a Therapeutic Educational Approach: A Feasibility Study
    Aurélie Bourmaud, Vanessa Rousset, Véronique Régnier Denois, Olivier Collard, Jean-Philippe Jacquin, Yacine Merrouche, J. Lapoirie, Fabien Tinquaut, Laurence Lataillade, Franck Chauvin · 2016 · Oncology nursing forum
  48. Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review
    Seongwoo Yang, Seong Won Park, Soong June Bae, Sung Gwe Ahn, Joon Jeong, Kyounghoon Park · 2023 · Journal of Breast Cancer
  49. Exploring the influence of a user-specific explainable virtual advisor on health behaviour change intentions
    Amal Abdulrahman, Deborah Richards, AYSE AYSIN BOMBACI BILGIN · 2022 · Autonomous Agents and Multi-Agent Systems
  50. Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer
    Ida Dragvoll, Anna Mary Bofin, Håvard Søiland, Gunnar Taraldsen, Monica Jernberg Engstrøm · 2022 · BMC Cancer
  51. There's many a slip twixt cup and lip: adherence issues in cancer therapy
    Lesley J. Fallowfield · 2008 · Nature Clinical Practice Oncology
  52. Effects of aromatase inhibitors and body mass index on steroid hormone levels in women with early and advanced breast cancer
    K M Elliott, Jennifer E. Dent, Frank Z. Stanczyk, Laura Woodley, R. Charles Coombes, Agam Purohit, Carlo Palmieri · 2014 · British journal of surgery
  53. Adherence to oral anticancer hormonal therapy in breast cancer patients and its relationship with treatment satisfaction: an important insight from a developing country
    Amer A. Koni, Bushra A. Suwan, Maisa Ayman Nazzal, Alaa Sleem, Aiman Daifallah, Majd Hamed Allah, Razan Y. Odeh, Sa’ed H. Zyoud · 2023 · BMC Women s Health
  54. NADA Ear Acupuncture for Breast Cancer Treatment–Related Hot Flashes and Night Sweats: An Observational Study
    Beverley A. de Valois, Teresa Young, Nicola Robinson, Christine McCourt, Elizabeth Jane Maher · 2012 · Medical Acupuncture
  55. Accompagnement des dépendances à l’alcool et au tabac des patients atteints d’un cancer des voies aérodigestives supérieures
    Chloé Hamant, Sophie Deneuve, Marie Alexandra Albaret, Philippe Zrounba, Pierre Breton, Philippe Céruse, Arnaud M. Gleizal, T. Alix, G. Bettega, Franck Chauvin et al. · 2018 · Bulletin du Cancer
  56. Intentional- but not Unintentional Medication Non-adherence was Related with Beliefs about Medicines Among a Multi-Ethnic Sample of People with HIV
    Anjuly Castelan, Jeannine F. Nellen, Marc van der Valk, Pythia T. Nieuwkerk · 2022 · AIDS and Behavior
  57. Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere
    Jeffrey I. Campbell, Nir Eyal, Angella Musiimenta, Bridget Burns, Sylvia Natukunda, Nicholas Musinguzi, Jessica Elizabeth Haberer · 2018 · AIDS and Behavior
  58. Appreciating Reasons for Nonadherence in Women
    Jennifer G. Okonsky, Allison R. Webel, Carol Dawson Rose, Mallory O. Johnson, Alice K. Asher, Yvette P. Cuca, Alphoncina Kaihura, Jan E. Hanson, Carmen J. Portillo · 2014 · Health Care For Women International
  59. Helping breast cancer patients adhere to oral adjuvant hormonal therapy regimens
    Ann H. Partridge, Terri B. Ades, Patricia Spicer, Linda Englander, Donald Lawrence Wickerham · 2007 · Community Oncology
  60. Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center
    Jochen Hefner, Sara Berberich, Elena Lanvers, Maria Sanning, Ann-Kathrin Steimer, Volker Kunzmann · 2018 · Patient Preference and Adherence
  61. In Search of Embodied Conversational and Explainable Agents for Health Behaviour Change and Adherence
    Abdulrahman, Amal, Richards, Deborah · 2021 · Multimodal Technologies and Interaction
  62. Role of the Nurse in Patient Education and Engagement and Its Importance in Advanced Breast Cancer
    Catherine Mary Oakley, Emma Ream · 2023 · Seminars in Oncology Nursing
  63. An accurate method of measuring shoulder sling compliance: a validation study
    Anshum Sood, Ashley Klein, Samir Kaveeshwar, Derek L. Jones, Grant T. Duvall, James Paul Hovis, Tristan B. Weir, Blessing Enobun, S. Ashfaq Hasan, R. Frank Henn et al. · 2021 · BMC Musculoskeletal Disorders
  64. Providers’ perspectives on adherence to hormonal therapy in breast cancer survivors. Is there a role for the digital health feedback system?
    Alejandra Hurtado‐de‐Mendoza, Mark L. Cabling, Asma Ali Dilawari, Jeanine Warisse Turner, Nicole C. Fernández, Alesha Henderson, Qi Zhu, Sara Gómez‐Trillos, Vanessa B. Sheppard · 2018 · Health and Technology
  65. Moving Research From Bench to Bedside to Community: There Is Still More to Do
    Katherine Leslie Kahn · 2008 · Journal of Clinical Oncology
  66. Physician–patient alignment on menopause-associated symptom burden: real-world evidence from the USA and Europe
    Sheryl A. Kingsberg, Rossella Elena Nappi, Megan Scott, Nils Schoof, Carsten Möeller, Lauren Lee, Cecile Janssenswillen, Cecilia Caetano, Victoria Banks · 2024 · Climacteric
  67. Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
    Cynthia Mayte Villarreal-Garza, Fernanda Mesa-Chávez, Ana S. Ferrigno, Cynthia De la Garza‐Ramos, Alan Fonseca, Karen Villanueva-Tamez, Jose Yair Campos-Salgado, Marlid Cruz‐Ramos, David O. Rodriguez-Gomez, Sandy Ruiz-Cruz et al. · 2021 · The Breast
  68. Relationship of adherence to treatment with disease activity, physical function, quality of life, treatment satisfaction and beliefs in axial spondyloarthritis patients
    Basma R. Sakr, Heba E Mohamed, Dina Effat · 2021 · The Egyptian Rheumatologist
  69. Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors
    Matea Baković, Martina Bago, Lucija Benić, Magdalena Krajinović, Tajana Silovski, Natalija Dedić Plavetić, Lu Turković, Miranda Sertić, Maja Ortner Hadžiabdić · 2023 · Acta Pharmaceutica
  70. Evaluation of prescribed medication pattern and adherence to treatment plans among breast cancer patients at KHCC
    et. al. Zainab Zakaraya · 2023 · Periodicals of Engineering and Natural Sciences (PEN)
  71. Plasma MMP1, MMP8 and MMP13 expression in breast cancer: protective role of MMP8 against lymph node metastasis
    Julie V. Decock, Wouter Hendrickx, Ulla Vanleeuw, Christiaens, Shu Ye, Robert Paridaens · 2008 · Breast Cancer Research
  72. Adherence to Hepatitis B Antiviral Therapy
    Suzanne Polis, Iryna Zablotska, Amany Zekry, Lisa Maher · 2017 · Gastroenterology Nursing
  73. Precautions for Patients Taking Aromatase Inhibitors
    Mary Heery, Stephen Farley, Rhett Sparkman, John Healy, William Eighmy, George Zahrah, Richard Zelkowitz · 2020 · Journal of the Advanced Practitioner in Oncology
  74. Prevalence and Patient-Level Correlates of Intentional Non-Adherence to Immunosuppressive Medication After Heart-Transplantation—Findings From the International BRIGHT Study
    Mark T. Marston, Lut Berben, Fabienne Dobbels, Cynthia L. Russell, Sabina De Geest · 2023 · Transplant International
  75. A competing risk analysis of hormone therapy interruption in Asian women with breast cancer
    Kun‐Pin Hsieh, Li‐Chia Chen, Kwok‐Leung Cheung, Yi‐Hsin Yang · 2014 · Pharmacoepidemiology and Drug Safety
  76. Factorial invariance of a questionnaire assessing medication beliefs in Japanese non-adherent groups
    Naomi Iihara, Kiyo Suzuki, Yuji Kurosaki, SHUSHI MORITA, Keizo Hori · 2010 · Pharmacy World & Science
  77. Prospective and retrospective memory are differentially related to self-rated omission and commission errors in medication adherence in multimorbidity
    Andreas Ihle, Jennifer Inauen, Urte Scholz, Claudia König, Barbara M. Holzer, Lukas Zimmerli, Edouard Battegay, Robert M. Tobias, Matthias Kliegel · 2016 · Applied Neuropsychology Adult
  78. Which bisphosphonates do oncologists prescribe for women with metastatic breast cancer and why? Results of a UK survey
    Lesley J. Fallowfield, Valerie A. Jenkins, Robert Edward Coleman · 2008 · The Breast
  79. An exploration of patients' perceived control, self efficacy and involvement in self care during chemotherapy for colorectal cancer
    Lisa Kidd · 2007 · Stirling Online Research Repository (University of Stirling)
  80. Long-Term Adherence to Levothyroxine Replacement Therapy in Thyroidectomized Patients
    Raffaella Bocale, Giovambattista Desideri, Angelina Barini, Annamaria D’Amore, Mauro Boscherini, Stefano Necozione, Celestino Pio Lombardi · 2022 · Journal of Clinical Medicine
  81. “Interventions to increase adherence to oral therapies in breast cancer patients: A systematic review based on the behavior change technique taxonomy”
    Massimo Pezzolato, Chiara Marzorati, Lucilla Lanzoni, Dario Monzani, Marianna Agnese Masiero, Ricardo S. Pietrobon, Gabriella Pravettoni · 2023 · Psycho-Oncology
  82. Bevacizumab resistance in breast cancer: are neuropilins the key?
    C A Staton, Zhiyong Yang, Malcolm Reed, Nicola Jane Brown · 2008 · Breast Cancer Research
  83. Prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome
    Andrew R. Green, Claire Burney, CJ Granger, Emma C. Paish, S El-Sheikh, Emad A. Rakha, DG Powe, R. Douglas Macmillan, Ian Ogilvie Ellis, Eleni Stylianou · 2008 · Breast Cancer Research
  84. Métodos de valoración de la adherencia al tratamiento psiquiátrico en la práctica clínica
    Carlos De las Cuevas, Emílio J. Sanz · 2015 · Revista Iberoamericana de Psicología y Salud
  85. Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy
    Sofia F. Garcia, Robert J. Gray, Joseph A. Sparano, Amye Juliet Tevaarwerk, Ruth C. Carlos, Betina R. Yanez, Ilana F. Gareen, Timothy Joseph Whelan, George W. Sledge, David F Cella et al. · 2021 · Cancer
  86. Codevelopment of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods Approach
    Sophie M C Green, David French, Louise Hall, Yvonne Kiera Bartlett, Nikki S. Rousseau, Erin Raine, Catherine Parbutt, Benjamin Gardner, ROSETA Investigators, Samuel George Smith · 2023 · Journal of Medical Internet Research
  87. Are women with breast cancer receiving sufficient education and information about their treatment?
    Yvonne Wengström · 2007 · Nature Clinical Practice Oncology
  88. Improved Patient Management Using eHealth Tools: Potential and Pitfalls
    Nadia Harbeck, Rachel Wuerstlein, Timo Schinkoethe · 2015 · Breast Cancer Management
  89. Adherence to Recommended Treatments for Early Invasive Breast Cancer: Decisions of Women Attending Surgeons in the Breast Cancer Audit of Australia and New Zealand
    David Murray Roder, Primali de Silva, Helen M. Zorbas, Fleur Webster, James Kollias, Christopher Pyke, Ian D Campbell · 2012 · Asian Pacific Journal of Cancer Prevention
  90. THE MEDIATING ROLE OF POSITIVE AND NEGATIVE EMOTIONAL ATTRACTORS BETWEEN PSYCHOSOCIAL CORRELATES OF DOCTOR-PATIENT RELATIONSHIP AND TREATMENT ADHERENCE IN TYPE 2 DIABETES
    Masud Khawaja · 2011 · OhioLink ETD Center (Ohio Library and Information Network)
  91. When can cancer patient treatment nonadherence be considered intentional or unintentional? A scoping review
    Leon Wreyford, Raj Gururajan, Xujuan Zhou · 2023 · PLoS ONE
  92. Self-management Strategies Adopted by Breast Cancer Survivors to Improve their Adherence to Tamoxifen
    Aline Sarradon‐Eck, Isabelle Pellegrini, Rémy Largillier, Ségolène Duran, Agnes Richard Tallet, Carole Tarpin, Claire Julian‐Reynier · 2012 · The Breast Journal
  93. Adjuvant aromatase inhibitors and emerging quality-of-life considerations
    Susanne Briest, Vered Stearns · 2007 · Expert Review of Anticancer Therapy
  94. Validation d’un questionnaire mesurant l’adhérence et les compétences de gestion des effets secondaires chez des patients traités par capécitabine
    Amandine Baudot, Mathieu Oriol, Fabien Tinquaut, Valentin Moine, Guillaume Moriceau, Thierry Muron, Cécile Pacaut, Olivier Collard, Jean-Philippe Jacquin, Léa Saban-Roche et al. · 2016 · Bulletin du Cancer
  95. Impact of persistence on survival of patients with breast cancer treated with endocrine therapy in Northeast China: a prospective study
    Peng Xing, Huiting Dong, Qun Liu, Fan Yao, Yingying Xu, Bo Chen, Xinyu Zheng, Yunfei Wu, Feng Jin, Jiguang Li · 2017 · Oncotarget
  96. Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy
    Sophie M C Green, David French, Christopher D. Graham, Louise Hall, Nikki S. Rousseau, Robbie Foy, Jane Clark, Catherine Parbutt, Erin Raine, Benjamin Gardner et al. · 2022 · Research Square
  97. A Phenomenological Approach to Medication Adherence in Elderly Patients: A Qualitative Study
    Gloria Liquori, Nicolò Panattoni, Aurora De Leo, Sara Dionisi, Noemi Giannetta, Beatrice Gasperi, Giovanni Battista Orsi, Flavio Di Muzio, Marco Di Muzio, Emanuele Di Simone · 2024 · Healthcare
  98. Interactions between BRCA2 protein and the meiosis-specific recombinase DMC1
    Tina Thorslund, Fumiko Esashi, Stephen Craig West · 2008 · Breast Cancer Research
  99. Assessment of angiogenesis in the hyperplasia preinvasive, invasive breast carcinoma sequence
    J. E. Bluff, Simon S. Cross, Nicola Jane Brown, Malcolm Reed, C A Staton · 2008 · Breast Cancer Research
  100. De novo expression of αvβ6 integrin by myoepithelial cells in ductal carcinoma in situ may be an important marker of disease progression
    Michael D. Allen, K Mulligan, Sarah Elizabeth Clark, Ian R. Hart, John F. Marshall, JL Jones · 2008 · Breast Cancer Research